Amgen Inc. (AMGN)

NASDAQ

$434.62

$+10.08

(+2.37%)

Regular Market

Amgen Inc. (AMGN) Live Price Chart

Last updated: ⁦2026-10-20 18:47:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Amgen Inc. (AMGN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $434.62, with a market capitalization of $233.82B and a P/E ratio of 26.28. Over the past 52 weeks, its price has ranged from $288.00 to $447.03. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$233.82B
Open	$425.58
Day's High	$447.03
Day's Low	$27.00
Previous Close	$424.94
Volume	1.08M
Average Volume	2.82M
P/E Ratio	26.28
52-Week High	$447.03
52-Week Low	$288.00
Dividend Yield	2.30%
Earnings Date	2001-12-30

Amgen Inc. (AMGN) Stock Price Today

Amgen Inc. (AMGN) is currently trading at $434.62 as of 2026-10-20 18:30:13, up 2.28% ($9.68) from the previous close of $424.94

During today's regular trading session, AMGN has traded between $27.00 and $447.03, with a trading volume of 1.08M shares. The current price is near the upper end of today's range.

Amgen Inc. (AMGN) 7-Day Stock Price Change

Over the past seven days, Amgen Inc. (AMGN) moved from $414.87 to $434.62, representing a gain of 4.76% ($19.75).

The stock traded between $404.05 and $441.76 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 2.79 million shares, up versus the previous seven-day period, indicating higher trading activity.

AMGN 52-Week Price Position

Position in Range: 92.2%

52W Low$288.00

52W High$447.03

AMGN is currently trading at $434.62, placing it 92.2% of the way from its 52-week low of $288.00 to its 52-week high of $447.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Amgen Inc. (AMGN)?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	31500
CEO	Robert A. Bradway
Founded	1980
Exchange	NASDAQ
Company Website	https://www.amgen.com

How to Buy Amgen Inc. (AMGN) Stock on MEXC

Eligible investors can buy real shares of Amgen Inc. (AMGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AMGN and Place Your Order

Open the RealStocks trading page and search for AMGN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Amgen Inc. (AMGN) stock price today?

Amgen Inc. (AMGN) is currently trading at $ 434.62, up 2.28% ($9.68) from the previous close of $ 424.94. Intraday prices update in real time during regular trading hours.

2.Is AMGN stock going up or down today?

As of 2026-10-20 18:30:13, AMGN is trading at $ 434.62, up 2.28% ($9.68) from its previous close of $ 424.94. The stock has traded between $ 27.00 and $ 447.03 during today’s regular session. Past price movements do not guarantee future results.

3.What is AMGN pre-market price?

As of 2026-10-20 18:30:13, AMGN is trading at $ 429.07 in pre-market trading, up 0.97% ($4.13) from the previous close of $ 424.94. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AMGN after-hours price?

As of 2026-10-20 18:30:13, AMGN is trading at $ 427.07 in after-hours trading, up 0.50% ($2.13) from the regular-session close of $ 424.94. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AMGN stock trading now?

AMGN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AMGN sit relative to its 52-week high and low?

Over the past 52 weeks, AMGN has traded between a low of $ 288.00 and a high of $ 447.03. At $ 434.62, the stock is positioned 92.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Amgen Inc. in?

Amgen Inc. (AMGN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Amgen Inc.'s market capitalization and where is it listed?

Amgen Inc. is listed on the NASDAQ exchange with a market capitalization of $ 233.82B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AMGN valued in terms of P/E ratio and EPS?

AMGN trades at a P/E ratio of 26.28, based on trailing-twelve-month EPS of $ 16.17. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Amgen Inc. pay a dividend?

Amgen Inc. pays an indicated annual cash dividend of $ 10.00 per share, with a current dividend yield of 2.30% based on the latest share price. Dividend policies are subject to change at the board's discretion.